The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used ...
A newly issued alert links certain FreeStyle Libre 3 and 3 Plus glucose-monitoring sensors to at least seven deaths and ...
Abbott initiated a nationwide voluntary medical device correction in February to emphasize instructions for the safe and proper use of its FreeStyle Libre®, FreeStyle Libre® 14 day, and FreeStyle ...
The issue affected about 3 million Libre 3 and Libre 3 Plus sensors in the U.S. and globally Abbott has received reports of 736 serious health problems (57 in the U.S.) and seven deaths (none in the U ...
The decision to recall approximately three million sensors follows reports of potentially life-threatening errors in the ...
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been ...
FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...
Tandem Diabetes Care (TNDM) begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with ...
Malfunctioning FreeStyle Libre 3 and Libre 3 Plus glucose sensors have been tied to seven possible deaths and hundreds of ...
Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
The t:slim X2™ Insulin Pump with Abbott’s FreeStyle Libre® 3 Plus Sensor is now available in the United States, beginning global commercial rollout. Tandem Diabetes Care begins global commercial ...